SMTL ID : 7avz.1

MerTK kinase domain in complex with a bisaminopyrimidine inhibitor

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.04 Å

Oligo State

monomer

Ligands

1 x S4N: (R)-N2-(4-(cyclopropylmethoxy)-3,5-difluorophenyl)-5-(3-methylpiperazin-1-yl)-N4-(tetrahydro-2H-pyran-4-yl)pyrimidine-2,4-diamine(Non-covalent)

S4N.1: 16 residues within 4Å: Chain A: L.27, V.35, A.51, I.84, L.105, P.106, F.107, M.108, K.109, G.111, D.112, R.161, N.162, M.164, A.174, D.175 5 PLIP interactions: 5 interactions with chain A Hydrophobic interactions: A:A.51, A:D.175 Hydrogen bonds: A:P.106, A:M.108, A:K.109

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Nissink, J.W.M. et al., Generating Selective Leads for Mer Kinase Inhibitors-Example of a Comprehensive Lead-Generation Strategy. J.Med.Chem. (2021)

Release Date

2021-03-03

Peptides

Tyrosine-protein kinase Mer: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Tyrosine-protein kinase Mer

Related Entries With Identical Sequence